⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 9, 2024VaccinesOpen Access

Long-Term Protective Immunity against Ehrlichia chaffeensis Infection Induced by a Genetically Modified Live Vaccine

Swetha Madesh Jodi L. McGill Deborah C. Jaworski Jonathan Ferm Huitao Liu Shawna Fitzwater Paidashe Hove Dominica Ferm Arathy Nair Cheyenne A. Knox Kimia Alizadeh A. Thackrah Roman R. Ganta

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Human monocytic ehrlichiosis, an emerging tick-borne disease, is caused by

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Madesh et al. (2024) studied this question.

synapsesocial.com/papers/68e5cdb1b6db643587563c5b https://doi.org/10.3390/vaccines12080903

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogenOriginal Research · 2026 · 1 citations
2Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent, <i>Borreliella burgdorferi</i>2024 · 7 citations
3Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensisOriginal Research · 1996 · 71 citations
4Survival, Replication, and Antibody Susceptibility ofEhrlichia chaffeensisoutside of Host Cellspreclinical · 2003 · 48 citations
5Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosisOriginal Research · 1994 · 189 citations